Central Trust CO Gilead Sciences, Inc. Transaction History

Central Trust CO

$4.19 Billion
Q3 2024

A detailed history of Central Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Central Trust CO holds 19,891 shares of GILD stock, worth $1.76 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

19,891

Previous 22,457 11.43%

Holding current value

$1.76 Million

Previous $1.54 Million 8.25%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$66.59 - $83.99 $170,869 - $215,518	-2,566 Reduced 11.43%	19,891 $1.67 Million
Q2 2024 Aug 05, 2024	SELL	$63.15 - $72.88 $4,420 - $5,101	-70 Reduced 0.31%	22,457 $1.54 Million
Q1 2024 Apr 24, 2024	SELL	$71.58 - $87.29 $74,729 - $91,130	-1,044 Reduced 4.43%	22,527 $1.65 Million
Q4 2023 Jan 24, 2024	SELL	$73.27 - $83.09 $21,541 - $24,428	-294 Reduced 1.23%	23,571 $1.91 Million
Q3 2023 Oct 26, 2023	SELL	$73.94 - $80.67 $15,675 - $17,102	-212 Reduced 0.88%	23,865 $1.79 Million
Q2 2023 Jul 26, 2023	SELL	$76.01 - $86.7 $206,215 - $235,217	-2,713 Reduced 10.13%	24,077 $1.86 Million
Q1 2023 Apr 19, 2023	SELL	$77.31 - $88.08 $32,160 - $36,641	-416 Reduced 1.53%	26,790 $2.22 Million
Q4 2022 Jan 26, 2023	SELL	$62.32 - $89.47 $11,716 - $16,820	-188 Reduced 0.69%	27,206 $0
Q3 2022 Nov 17, 2022	BUY	$59.54 - $68.01 $191,123 - $218,312	3,210 Added 13.27%	27,394 $1.69 Million
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $519 - $585	-9 Reduced 0.04%	24,184 $1.5 Million
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $76,801 - $96,241	-1,326 Reduced 5.2%	24,193 $1.44 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $37,435 - $42,490	577 Added 2.31%	25,519 $1.85 Million
Q3 2021 Oct 19, 2021	BUY	$67.69 - $73.03 $67,554 - $72,883	998 Added 4.17%	24,942 $1.74 Million
Q2 2021 Jul 23, 2021	SELL	$63.47 - $69.35 $67,595 - $73,857	-1,065 Reduced 4.26%	23,944 $1.65 Million
Q1 2021 Apr 23, 2021	BUY	$60.0 - $68.46 $32,400 - $36,968	540 Added 2.21%	25,009 $1.62 Million
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $1.94 Million - $2.21 Million	-34,306 Reduced 58.37%	24,469 $1.43 Million
Q3 2020 Oct 22, 2020	SELL	$62.1 - $78.08 $395,577 - $497,369	-6,370 Reduced 9.78%	58,775 $3.71 Million
Q2 2020 Jul 14, 2020	BUY	$72.34 - $84.0 $694,681 - $806,652	9,603 Added 17.29%	65,145 $5.01 Million
Q1 2020 Apr 17, 2020	BUY	$62.63 - $80.22 $1.59 Million - $2.03 Million	25,326 Added 83.82%	55,542 $4.15 Million
Q4 2019 Jan 21, 2020	BUY	$61.62 - $67.78 $150,352 - $165,383	2,440 Added 8.78%	30,216 $1.96 Million
Q3 2019 Oct 28, 2019	BUY	$62.51 - $69.0 $26,191 - $28,911	419 Added 1.53%	27,776 $1.76 Million
Q2 2019 Jul 12, 2019	SELL	$61.87 - $69.38 $24,624 - $27,613	-398 Reduced 1.43%	27,357 $0
Q1 2019 Apr 26, 2019	SELL	$62.53 - $70.05 $65,031 - $72,852	-1,040 Reduced 3.61%	27,755 $0
Q4 2018 Jan 08, 2019	SELL	$60.54 - $79.0 $16,587 - $21,646	-274 Reduced 0.94%	28,795 $1.8 Million
Q3 2018 Oct 04, 2018	SELL	$71.28 - $78.92 $1.79 Million - $1.98 Million	-25,118 Reduced 46.35%	29,069 $0
Q2 2018 Jul 09, 2018	SELL	$64.88 - $75.68 $355,801 - $415,029	-5,484 Reduced 9.19%	54,187 $0
Q1 2018 Apr 04, 2018	SELL	$72.84 - $88.8 $793,446 - $967,298	-10,893 Reduced 15.44%	59,671 $0
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $60,619 - $71,159	-852 Reduced 1.19%	70,564 $0
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $5.15 Million - $6.1 Million	71,416	71,416 $0

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account